Human papilloma viruses ([hpv]{.smallcaps}s) are causally associated with genital warts, papillomata, and oral squamous cell carcinoma ([scc]{.smallcaps}) [@b1-co16-4-2],[@b2-co16-4-2]. oral [scc]{.smallcaps}, with or without keratosis, is the sixth-most prevalent cancer. Non-keratotic [scc]{.smallcaps} derives from transmission of [hpv]{.smallcaps} 16. uterine cervical cancer is also causally associated with [hpv]{.smallcaps} infection and strongly associated with [hpv]{.smallcaps} 16 and [hpv]{.smallcaps} 18. Transmission may occur during sexual intercourse, orogenital sexual contact, and saviolum kissing (when mutual insertion of tongues allows for saliva exchange with all of the associated biologic and microbial load) [@b2-co16-4-2],[@b3-co16-4-2].

Functionally, high-risk [hpv]{.smallcaps} infection contributes oncogenes E6 and E7, and 40 variants of E6 and E7 are related to speed of progression in the development of [scc]{.smallcaps}. The transcription factor nuclear factor κB (found in many tumours) and its activation pathway are targeted by the viruses [@b3-co16-4-2],[@b4-co16-4-2].

Gardasil (Merck Frosst Canada, Kirkland, QC) is a recombinant quadrivalent intramuscular injection vaccine derived from [hpv]{.smallcaps} types 6, 11, 16, and 18 [@b5-co16-4-2] that is approximately 90% effective at producing immunity against [hpv]{.smallcaps} infection and preventing [hpv]{.smallcaps} from causing [scc]{.smallcaps} in females.

Given that young, sexually active males are reservoir carriers and a major source of [hpv]{.smallcaps} infection and transmission, not only should young females be inoculated before commencing sexual activity, but young males should be similarly targeted with a preventive strategy.
